IL6 and COVID-19: In critically ill patients with COVID-19 and acute respiratory failure, we found that the occurrence of severe AKI was common and not associated with inflammatory (IL-6, ferritin, and C-reactive protein) or thromboembolism (D-dimer and fibrinogen) markers.